Private Equity and Venture Capital Funds in Developed Markets Outside US Outperformed Comparable Public Markets in 2016, According to Cambridge Associates Benchmarks

Meanwhile, Private Investment Funds in Emerging Markets Underperformed Their Public Market Counterparts In 2016, According to…

Continue Reading

MTBC Kicks Off National talkEHR Advertising Campaign

SOMERSET, NJ -- (Marketwired) -- 08/29/17 -- (NASDAQ: MTBC) (NASDAQ: MTBCP), a leading provider of mHealth…

Continue Reading

Amitree Raises $7 Million to Fuel Real Estate Software Innovation

Company--s Folio(TM) Email Transaction Assistant Already Managing ~5 Percent of All U.S. Real Estate Transactions

Continue Reading

Fronsac REIT Announces Continuous Growth for the Quarter Ended June 30th, 2017 and the September 29th, 2017 Regular Quarterly Distribution

MONTREAL, QUEBEC -- (Marketwired) -- 08/24/17 -- Fronsac Real Estate Investment Trust ("Fronsac REIT" or "Fronsac")…

Continue Reading

Woden Closes its Preliminary Private Placement for $225,000

MONTREAL, QUEBEC -- (Marketwired) -- 08/24/17 -- Woden Venture Capital Corporation ("Woden") (NEX: WOD.H) is pleased…

Continue Reading

NightFood Announces Record Sales Direct to Consumer in Consecutive Months

TARRYTOWN, NY -- (Marketwired) -- 08/23/17 -- NightFood Holdings, Inc. (OTCQB: NGTF), a fully reporting "better-for-you"…

Continue Reading

Major Diagnostic Laboratory Selects MTBC for Integrated Healthcare IT and Revenue Cycle Services

SOMERSET, NJ -- (Marketwired) -- 08/22/17 -- (NASDAQ: MTBC) (NASDAQ: MTBCP), a leading provider of proprietary,…

Continue Reading

Pacific Iron Ore Corporation Announces Release of June 30, 2017 Financial Statements and Management Discussion and Analysis

CALGARY, ALBERTA -- (Marketwired) -- 08/21/17 -- Pacific Iron Ore Corporation (TSX VENTURE: POC) announces that…

Continue Reading

Fronsac REIT Announces an Acquisition

MONTREAL, QUEBEC -- (Marketwired) -- 08/21/17 -- Fronsac Real Estate Investment Trust ("Fronsac REIT" or "Fronsac")…

Continue Reading

Ritter Pharmaceuticals Announces Phase 3 Plans after its End of Phase 2 Meeting with FDA on RP-G28 for Lactose Intolerance

Company has incorporated guidance from FDA on key elements of its Phase 3 program to support…

Continue Reading